139 related articles for article (PubMed ID: 16201577)
1. [Anti-angiogenesis treatment for brain tumors--present and future].
Takano S
Nihon Rinsho; 2005 Sep; 63 Suppl 9():534-9. PubMed ID: 16201577
[No Abstract] [Full Text] [Related]
2. [Anti-angiogenesis treatment for brain tumors: present and future].
Takano S; Matsumura A
No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
[No Abstract] [Full Text] [Related]
3. Bevacizumab in the treatment of high-grade gliomas: an overview.
Kunnakkat S; Narayana A
Angiogenesis; 2011 Dec; 14(4):423-30. PubMed ID: 21858651
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic treatment strategies for malignant brain tumors.
Kirsch M; Schackert G; Black PM
J Neurooncol; 2000; 50(1-2):149-63. PubMed ID: 11245274
[TBL] [Abstract][Full Text] [Related]
5. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
Kepes JJ
Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
[No Abstract] [Full Text] [Related]
6. [Angiogenesis suppressing therapy applied to malignant glioma].
Takano S
Gan To Kagaku Ryoho; 2009 Jun; 36(6):941-7. PubMed ID: 19579331
[No Abstract] [Full Text] [Related]
7. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
8. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
9. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic approaches to malignant gliomas.
Soffietti R; Trevisan E; Bertero L; Bosa C; Ruda R
Curr Cancer Drug Targets; 2012 Mar; 12(3):279-88. PubMed ID: 22229250
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
[TBL] [Abstract][Full Text] [Related]
12. Breast tumour angiogenesis.
Fox SB; Generali DG; Harris AL
Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and invasion in glioma.
Onishi M; Ichikawa T; Kurozumi K; Date I
Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
[TBL] [Abstract][Full Text] [Related]
14. [Development of monoclonal antibody therapy for brain tumors].
Mishima K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():569-77. PubMed ID: 16201583
[No Abstract] [Full Text] [Related]
15. Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors.
Puduvalli VK; Sawaya R
J Neurooncol; 2000; 50(1-2):189-200. PubMed ID: 11245279
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic therapy in the management of brain tumors: a clinical overview.
Kunnakkat S; Mathew M; Narayana A
Cancer Chemother Pharmacol; 2012 Sep; 70(3):353-63. PubMed ID: 22825032
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic strategies in neuroblastoma.
Ribatti D; Ponzoni M
Cancer Treat Rev; 2005 Feb; 31(1):27-34. PubMed ID: 15707702
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
19. [Angiogenesis research--quo vadis?].
Augustin HG
Ophthalmologe; 2003 Feb; 100(2):104-10. PubMed ID: 12589453
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
